Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 165 Print this page  Email this page Small font size Default font size Increase font size

    Article Cited by others

REVIEW ARTICLE

PET/CT imaging of neuroendocrine tumors with 68Gallium-labeled somatostatin analogues: An overview and single institutional experience from India

Sharma Punit, Singh Harmandeep, Bal Chandrasekhar, Kumar Rakesh

Year : 2014| Volume: 29| Issue : 1 | Page no: 2-12

   This article has been cited by
 
1 Long-term outcome of indigenous 177Lu-DOTATATE PRRT in patients with Metastatic Advanced Neuroendocrine Tumours: a single institutional observation in a large tertiary care setting
Keerti Sitani, Rahul V Parghane, Sanjay Talole, Sandip Basu
The British Journal of Radiology. 2021; 94(1117): 20201041
[Pubmed]  [Google Scholar] [DOI]
2 A Review of Streptococcus pyogenes: Public Health Risk Factors, Prevention and Control
Nelly Janira Avire, Harriet Whiley, Kirstin Ross
Pathogens. 2021; 10(2): 248
[Pubmed]  [Google Scholar] [DOI]
3 Evaluation of a Correction Method for 111In-Pentetreotide SPECT Imaging of Gastroenteropancreatic Neuroendocrine Tumors
Takao Kanzaki, Yasuyuki Takahashi, Tetsuya Higuchi, Xieyi Zhang, Nao Mogi, Takayuki Suto, Yoshito Tsushima
Journal of Nuclear Medicine Technology. 2020; 48(4): 326
[Pubmed]  [Google Scholar] [DOI]
4 Qualitative Analysis of Long-Lived Residual Radioisotopes in 18 MeV Proton Bombarded Enriched Water Target
I Kambali, H Suryanto, Rajiman, Parwanto, F Rindiyantono, A A Billah, Pasha
Journal of Physics: Conference Series. 2020; 1436(1): 012021
[Pubmed]  [Google Scholar] [DOI]
5 3P’s of Wermer/MEN1 Syndrome on 68Ga-DOTANOC PET/CT Scan
Sarthak Tripathy, Sneha Prakash, Sreedharan Thankarajan Arun Raj, Arunav Kumar, Shamim Ahmed Shamim
Clinical Nuclear Medicine. 2020; 45(12): e516
[Pubmed]  [Google Scholar] [DOI]
6 Peptide Receptor Radionuclide Therapy in the Management of Neuroendocrine Tumors (Neoplasms): Fundamentals and Salient Clinical Practice Points for Medical Oncologists
Sandip Basu, Rahul Parghane, Rohit Ranade, Pradeep Thapa, Anant Ramaswamy, Vikas Ostwal, Bhawna Sirohi, Dipanjan Panda, Shailesh V Shrikhande
Indian Journal of Medical and Paediatric Oncology. 2019; 40(02): 165
[Pubmed]  [Google Scholar] [DOI]
7 Nonfunctioning Incidental Pancreatic Neuroendocrine Tumors
Marina Gorelik, Mahmoud Ahmad, David Grossman, Martin Grossman, Avram M. Cooperman
Surgical Clinics of North America. 2018; 98(1): 157
[Pubmed]  [Google Scholar] [DOI]
8 Continued rapid growth in68Ga applications: update 2013 to June 2014
Irina Velikyan
Journal of Labelled Compounds and Radiopharmaceuticals. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
9 Approches de la médecine nucléaire au Liban dans les tumeurs neuroendocrines
F. Chehade,M. Ghosn,N. Hammoud,G. Mouharram,F. Farhat,J. Daher,M. Jreige,M. Haidar
Médecine Nucléaire. 2015;
[Pubmed]  [Google Scholar] [DOI]
10 PET imaging with 68gallium labelled somatostatin analogues in the evaluation of neuroendocrine tumours (NETs)
C. Ansquer,D. Taieb,F. Montravers,F. Tenenbaum
Médecine Nucléaire. 2015;
[Pubmed]  [Google Scholar] [DOI]
11 SPECT/CT in neuroendocrine tumours
Orazio Schillaci,Angela Spanu,Barbara Palumbo,Roberta Danieli
Clinical and Translational Imaging. 2014; 2(6): 477
[Pubmed]  [Google Scholar] [DOI]

 

Read this article